Leishmania major-Infected C3H Mice Treated with Anti-IL-12 mAb Develop but Do Not Maintain a Th2 Response

Journal of Immunology

Volumn 159, Issue 10, 1997, Pages 5024-5031

  Hondowicz, Brian D ^a   Scharton Kersten, Tanya M ^a   Jones, Douglas E ^a   Scott, Phillip ^a  

^a UNIVERSITY OF PENNSYLVANIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

GAMMA INTERFERON; INTERLEUKIN 12; MONOCLONAL ANTIBODY;

ANIMAL; ARTICLE; BAGG ALBINO MOUSE; BIOSYNTHESIS; C3H MOUSE; COMPARATIVE STUDY; FEMALE; GROWTH, DEVELOPMENT AND AGING; IMMUNOLOGY; INTRAPERITONEAL DRUG ADMINISTRATION; LEISHMANIA MAJOR; METABOLISM; MOUSE; PARASITOLOGY; SKIN LEISHMANIASIS; TH2 CELL;

ANIMALS; ANTIBODIES, MONOCLONAL; FEMALE; INJECTIONS, INTRAPERITONEAL; INTERFERON TYPE II; INTERLEUKIN-12; LEISHMANIA MAJOR; LEISHMANIASIS, CUTANEOUS; MICE; MICE, INBRED BALB C; MICE, INBRED C3H; TH2 CELLS;

EID: 0031573221     PISSN: 00221767     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (50)

1. Scott, P. 1993. IL-12: initiation cytokine for cell-mediated immunity. Science 260:496.
2. Gajewski, T. F., and F. W. Fitch. 1488. Anti-proliferative effect of IFN-γ in immune regulation. I. IFN-γ inhibits the proliferation of Th2 but not Th1 murine helper T lymphocyte clones. J. Immunol. 140:4245.
3. Fiorentino, D. F., M. W. Bond, and T. R. Mosmann. 1989. Two types of mouse T helper cells. IV. Th2 clones secrete a factor that inhibits cytokine production by Th1 clones. J. Exp. Med. 170:2081.
4. Locksley, R. M., and P. Scott. 1991. Helper T-cell subsets in mouse leishmaniasis: induction, expansion and effector function. Immunol. Today 12:A58.
5. Blackwell, J. M., C. Hale, M. B. Roberts, O. M. Ulczak, F. Y. Liew, and J. G. Howard. 1985. An H-11-linked gene has a parallel effect on L. major and L. donovani infections in mice. Immunogenetics 21:385.
6. DeTolla, L. J., P. A. Scott, and J. P. Farrell. 1981. Single gene control of resistance to cutaneous leishmaniasis in mice. Immunogenetics 14:29.
7. Mock, B., J. Blackwell, J. Hilgers, M. Potter, and C. Nacy. 1983. Genetic control of Leishmania major infection in congenic, recombinant inbred and F2 populations of mice. Eur. J. Immunogen. 20:335.
8. Roberts, M., B. A. Mock, and J. M. Blackwell. 1997. Mapping of genes controlling Leishmania major infection in CXS recombinant mice. Eur. J. Immunogen. 20:349.
9. Swain, S. L., A. D. Weinberg, M. English, and G. Huston. 1990. 1L-4 directs the development of Th2-like helper effectors. J. Immunol. 145:3796.
10. Chatelain, R., K. Varkila, and R. L. Coffman. 1992. IL-4 induces a Th2 response in Leishmania mojor-infected mice. J. Immunol. 148:1182.
11. Hsieh, C.-S., A. B. Heimberger, J. S. Gold, A. O'Garra, and K. M. Murphy. 1992. Differential regulation of T helper phenotype development by interleukins 4 and 10 in an α,β T-cell-receptor transgenic system. Proc. Natl. Acad. Sci. USA 89: 6065.
12. + T cells from T cell receptor transgenic mice. J. Exp. Med. 176:1091.
13. Swain, S. L., G. Huston, S. Tonkonogy, and A. Weinberg. 1991. Transforming growth factor-beta and IL-4 cause helper T cell precursors to develop into distinct effector helper cells that differ in lymphokine secretion pattern and cell surface phenotype. J. Immunol. 147:2991.
14. + T cells through IL-12 produced by Listeria-induced macrophages. Science 260:547.
15. Afonso, L. C. C., T. M. Scharton, L. Q. Vieira, M. Wysocka, G. Trinchieri, and P. Scott. 1994. The adjuvant effect of interleukin-12 in a vaccine against Leishmania major. Science 263:235.
16. McKnight, A. J., G. J. Zimmer, I. Fogelman, S. F. Wolf, and A. K. Abbas. 1994. Effects of IL-12 on helper T cell-dependent immune responses in vivo. J. Immunol. 152:2172.
17. Manetti, R., P. Parronchi, M. G. Giudizi, M.-P. Piccinni, E. Maggi, G. Trinchieri, and S. Romagnani. 1993. Natural killer cell stimulatory factor (NKSF/IL-12) induces Th1-type specific immune responses and inhibits the development of IL-4 producing Th cells. J. Exp. Med. 177:1199.
18. Romagnani, S. 1993. Regulatory role of IL-4 and other cytokines in the function and development of human T cell clones. Res. Immunol. 144:625.
19. Schmitt, E., P. Hoehm, T. Germann, and E. Rude. 1994. Differential effects of IL-12 on the development of naive mouse CD4(+) T cells. Eur. J. Immunol. 24:343.
20. Wu, C. Y., C. E. Demeure, M. Gately, F. Podlaski, M. Kiniwa, and G. Delespesse. 1994. In vitro maturation of human neonatal CD4 T lymphocytes. I. Induction of IL-4-producing cells after long term culture in the presence of IL-4 plus either IL-2 or IL-12. J. Immunol. 152:1141.
21. + T cells. J. Immunol. 151:1938.
22. Heinzel, F. P., D. S. Schoenhaut, R. M. Rerko, L. E. Rosser, and M. K. Gately. 1993. Recombinant Interleukin 12 cures mice infected with Leishmania major. J. Exp. Med. 177:1505.
23. Sypek, J. P., C. L. Chung, S. E. H. Mayor, J. M. Subramanyam, S. J. Goldman, D. S. Sieburth, S. F. Wolf, and R. G. Schaub. 1993. Resolution of cutaneous leishmaniasis: interleukin 12 initiates a protective Th1 immune response. J. Exp. Med. 177:1797.
24. Sadick, M. D., F. P. Heinzel, B. J. Holaday, R. T. Pu, R. S. Dawkins, and R. M. Locksley. 1990. Cure of murine leishmaniasis with anti-interleukin 4 monoclonal antibody: evidence for a T cell-dependent, interferon gamma-independent mechanism. J. Exp. Med. 171:115.
25. Belosevic, M., D. S. Finbloom, P. H. Van Der Meide, M. V. Slayter, and C. A. Nacy. 1989. Administration of monoclonal anti-IFN-gamma antibodies in vivo abrogates natural resistance of C3H/HeN mice to infection with Leishmania major. J. Immunol. 143:266.
26. Scott, P. 1991. IFN-gamma modulates the early development of Th1 and Th2 responses in a murine model of cutaneous leishmaniasis. J. Immunol. 147:3149.
27. Scharton-Kersten, T., L. C. C. Afonso, M. Wysocka, G. Trinchieri, and P. Scott. 1995. IL-12 is required for natural killer cell activation and subsequent T helper 1 cell development in experimental leishmaniasis. J. Immunol. 154:5320.
28. Heinzel, F. P., R. M. Rerko, F. Ahmed, and E. Pearlman. 1995. Endogenous IL-12 is required for control of Th2 cytokine responses. J. Immunol. 155:730.
29. + cells correlate with resolution of lesions in murine cutaneous leishmaniasis. J. Immunol. 149:2715.
30. + T cells are important for the balance between protective and pathogenic cell-mediated immunity. J. Exp. Med. 179:589.
31. Powrie, F., S. M. Menon, and R. L. Coffman. 1993. Interleukin-4 and interleukin-10 synergize to inhibit cell-mediated immunity in vivo. Eur. J. Immunol. 23:3043.
32. Mosmann, T. R., and R. L. Coffman. 1989. TH1 and TH2 cells: different patterns of lymphokine secretion lead to different functional properties. Annu. Rev. Immunol. 7:145.
33. Nabors, G. S., L. C. C. Afonso, J. P. Farrell, and P. Scott. 1995. Switch from a type 2 to a type 1 T helper cell response and cure of established Leishmania major infection in mice is induced by combined therapy with interleukin-12 and pentostam. Proc. Natl. Acad. Sci. USA 92:3142.
34. Sacks, D. H., and P. V. Perkins. 1984. Identification of an infective stage of Leishmania promastigotes. Science 223:1417.
35. Scott, P., E. Pearce, P. Natovitz, and A. Sher. 1987. Vaccination against cutaneous leishmaniasis in a murine model. I. Induction of protective immunity with a soluble extract of promastigotes. J. Immunol. 139:221.
36. Reiner, S. L., S. Zheng, D. B. Corry, and R. M. Locksley. 1993. Constructing polycompetitor cDNAs for quantitative PCR. J. Immunol. Methods 165:37.
37. Chomczynski, P., and N. Sacchi. 1987. Single-step method of RNA isolation by acid guanidinium thiocyante-phenol-chloroform extraction. Anal. Biochem. 162: 156.
38. Mosmann, T. R., and T. A. T. Fong. 1989. Specific assays for cytokine production by T cells. J. Immunol. Methods 116:151.
39. Bretscher, P. A., G. Wei, J. N. Menon, and H. Bielefeldt-Ohmann. 1992. Establishment of stable, cell-mediated immunity that makes "susceptible" mice resistant to Leishmania major. Science 257:539.
40. Abbas, A. K., K. M. Murphy, and A. Sher. 1996. Functional diversity of helper T lymphocytes. Nature 383:787.
41. Powrie, F., S. Menon, and R. L. Coffman. 1993. Interleukin-4 and interleukin-10 synergize to inhibit cell-mediated immunity in vivo. Eur. J. Immunol. 23:3043.
42. + T cells to C.B-17 SCID mice: a model to study Th1 and Th2 cell differentiation and regulation in vivo. Res. Immunol. 145:347.
43. Mocci, S., and R. L. Coffman. 1995. Induction of a Th2 population from a polarized Leishmania-speciftc Th1 population by in vitro culture with IL-4. J. Immunol. 154:3779.
44. + T cells from allergic individuals is modulated by antigen concentration and antigen-presenting cell type. J. Exp. Med. 181:1081.
45. Hondowicz, B., and P. Scott. 1996. The role of IL-12 in modulating an established Th2 response in experimental leishmaniasis. Res. Immunol. 146:560.
46. Stenger, S., H. Thuring, M. Rollinghoff, and C. Bogdan. 1994. Tissue expression of inducible nitric oxide synthase is closely associated with resistance to Leishmania major. J. Exp. Med. 180:783.
47. Farrell, J. P., and C. P. Kirkpatrick. 1987. Experimental cutaneous leishmaniasis. II. A possible role for prostaglandins in exacerbation of disease in Leishmania major-infected BALB/c mice. J. Immunol. 138:902.
48. Szabo, S. L., N. G. Jacobson, A. S. Dighe, U. Gubler, and K. H. Murphy. 1995. Developmental commitment to the Th2 lineage by extinction of IL-12 signaling. Immunity 2:665.
49. Guler, M. L., J. D. Gorham, C.-S. Hsieh, A. J. Mackey, R. G. Steen, W. F. Dietrich, and K. M. Murphy. 1996. Genetic susceptibility to Leishmania: IL-12 responsiveness in Th1 cell development. Science 271:984.
50. Jacobson, N. G., S. J. Szabo, M. L. Guler, J. D. Gorham, and K. M. Murphy. 1996. Regulation of interleukin-12 signal transduction during T helper cell phenotype development. Res. Immunol. 146:446.